Comparison of Full-Dose vs Moderate-Dose Systemic Thrombolysis for the Treatment of Patients With Acute Pulmonary Embolism-Reference-Cited by-同舟云学术

Comparison of Full-Dose vs Moderate-Dose Systemic Thrombolysis for the Treatment of Patients With Acute Pulmonary Embolism

Published:2022-08 Issue:2 Volume:162 Page:448-451
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Jaureguízar Ana^ORCID,Ochoa Chaar Cassius Iyad,Muriel Alfonso^ORCID,Vela Moreno Jerónimo Ramón,Weinberg Ido^ORCID,Tufano Antonella,Varona José F.,Bikdeli Behnood,Jiménez David,Monreal Manuel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference4 articles.

1. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism;Wang;Chest,2010

2. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial);Sharifi;Am J Cardiol,2013

3. Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: the BACS score;Jara-Palomares;Eur Respir J,2020

4. The role of thrombolytic therapy in pulmonary embolism;Wang;Blood,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of race, ethnicity and insurance status with outcomes for patients with acute pulmonary embolism treated by PERT: a retrospective observational study;Respiratory Research;2024-06-24

2. Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary Embolism;JAMA Cardiology;2022-12-01